Cui Liao, Wu Tie, Liu Xiao-qing, Liu Yu-yu, Li Qing-nan
Department of Pharmacology, Guangdong Medical College, Zhanjiang 524023, China.
Yao Xue Xue Bao. 2002 Jul;37(7):501-5.
To determine whether low dose of estrogen in combination with ginsenosides can completely prevent bone loss in ovariectomized rats.
Four-month-old ovariectomized rats were treated either with 100 and 300 mg.kg-1 of ginsenosides or 30 and 100 micrograms.kg-1 of 17 alpha-ethynylestradiol alone, or ginsenosides 100 mg.kg-1 in combination with 17 alpha-ethynylestradiol 30 micrograms.kg-1 for 10 weeks. Double in vivo fluorochrome labeling was made. The undecalcified longitudinal proximal tibial metaphyseal sections were processed and stained with Goldner's trichrome for histomorphometric analysis of the bone.
Body weights and serum cholesterol were increased in ovariectomized (OVX) rats. The rats lost 74% of bone volume and high bone turnover was induced after OVX compared with the sham group. Bone volume increased by 205% in the high dose estrogen treated group while it was increased by 105% in the low dose group. The two doses of estrogen were shown to inhibit osteoclasts surface (by -65% and -55%, P < 0.01) and decrease bone turnover rate (by -85% and -83%, P < 0.01). High dose of estrogen was found to inhibit growth and stimulate uterine weight gain in rats while low dose did not. High dose of ginsenosides increased bone volume by 84% (P < 0.01) and decreased bone turnover rate by -64% (P < 0.05) while lower dose of ginsenosides did not. However, low dose ginsenosides combined with low dose estrogen achieved well preventive effects: increase of 202% in bone volume, decrease of 66% in bone turnover rate and 72% in osteoclasts surface. The combined effect in preventing bone loss equals to that the high dose of estrogen alone did.
Use of low dose of estrogen plus ginsenosides showed synergistic effect on prevention of osteoporosis induced by ovariectomy.
确定低剂量雌激素与人参皂苷联合使用是否能完全预防去卵巢大鼠的骨质流失。
对4月龄去卵巢大鼠分别给予100和300mg·kg-1人参皂苷、30和100μg·kg-1 17α-乙炔雌二醇单独处理,或给予100mg·kg-1人参皂苷与30μg·kg-1 17α-乙炔雌二醇联合处理,持续10周。进行双重体内荧光染料标记。对未脱钙的胫骨近端干骺端纵向切片进行处理,并用戈德纳三色染色法进行骨组织形态计量分析。
去卵巢(OVX)大鼠体重和血清胆固醇升高。与假手术组相比,去卵巢后大鼠骨体积减少74%,并诱导了高骨转换。高剂量雌激素治疗组骨体积增加205%,低剂量组增加105%。两种剂量的雌激素均显示可抑制破骨细胞表面(分别降低65%和55%,P<0.01)并降低骨转换率(分别降低85%和83%,P<0.01)。发现高剂量雌激素可抑制大鼠生长并刺激子宫重量增加,而低剂量则无此作用。高剂量人参皂苷使骨体积增加84%(P<0.01),骨转换率降低64%(P<0.05),而低剂量人参皂苷则无此作用。然而,低剂量人参皂苷与低剂量雌激素联合使用取得了良好的预防效果:骨体积增加202%,骨转换率降低66%,破骨细胞表面降低72%。联合预防骨质流失的效果等同于单独使用高剂量雌激素的效果。
低剂量雌激素加人参皂苷对预防去卵巢诱导的骨质疏松具有协同作用。